BCTXZ

BriaCell Therapeutics Corp. (NASDAQ:BCTXZ) is a Canadian biotechnology company founded to develop innovative immunotherapies for cancer treatment. Based in West Vancouver, Canada, the company focuses on immuno-oncology, which is a field that harnesses the body's immune system to fight cancer. BriaCell has emerged as a clinical-stage biotechnology company with multiple drug candidates in development, including both personalized and off-the-shelf cancer immunotherapies. The company has established strategic partnerships with major pharmaceutical companies and government institutions to advance its clinical programs.